Observations on the Course of Exophthalmos After 131-I Therapy

Overview

Journal Proc R Soc Med

Specialty General Medicine

Date 1969 Jan 1

PMID 5818231

Citations 7

Authors

D I Jones

D S MUNRO

G M WILSON

Affiliations

Soon will be listed here.

Citing Articles

Prevalence and natural history of Graves' orbitopathy in the XXI century.

Piantanida E, Tanda M, Lai A, Sassi L, Bartalena L J Endocrinol Invest. 2013; 36(6):444-9.

PMID: 23587873 DOI: 10.3275/8937.

The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Bartley G Trans Am Ophthalmol Soc. 1994; 92:477-588.

PMID: 7886878 PMC: 1298522.

Endocrine exophthalmos.

Br Med J. 1972; 3(5818):68.

PMID: 5067997 PMC: 1785587.

Thyroid disorders--management.

Smith R Br Med J. 1970; 1(5698):745-8.

PMID: 4191695 PMC: 1699854. DOI: 10.1136/bmj.1.5698.745.

The effect of subtotal thyroidectomy on Graves' ophthalmopathy.

Levitt M, Edis A, Agnello R, McCormick C World J Surg. 1988; 12(5):593-7.

PMID: 3245214 DOI: 10.1007/BF01655858.

References

HALES I, RUNDLE F . Ocular changes in Graves' disease. A long-term follow-up study. Q J Med. 1960; 29:113-26. View

Smith R, WILSON G . Clinical trial of different doses of 131-I in treatment of thyrotoxicosis. Br Med J. 1967; 1(5533):129-32. PMC: 1840602. DOI: 10.1136/bmj.1.5533.129. View

HAMILTON H, Schultz R, DE GOWIN E . The endocrine eye lesion in hyperthyroidism. Its incidence and course in 165 patients treated for thyrotoxicosis with iodine. Arch Intern Med. 1960; 105:675-85. View